Dosergoside
Appearance
![]() | |
Clinical data | |
---|---|
Other names | Lyrgosin; AF-1; N-(Dihydrolysergyl)sphingosine; N-((1S,2R,3E)-2-Hydroxy-1-(hydroxymethyl)-3-heptadecenyl)-6-methylergoline-8β-carboxamide |
Drug class | Dopamine agonist |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C34H53N3O3 |
Molar mass | 551.816 g·mol−1 |
3D model (JSmol) | |
| |
|
Dosergoside (INN ), also known as lyrgosin or N-(dihydrolysergyl)sphingosine, is a dopamine agonist of the ergoline and lysergamide families which was never marketed.[1] It is similar in chemical structure to lysergic acid diethylamide (LSD) but is 9,10-dihydrogenated and features a sphingosine moiety in place of LSD's N,N-diethylamide group.[1] The drug was first described in the literature by 1981.[1]
See also
[edit]References
[edit]- ^ a b c Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. p. 468. ISBN 978-1-4757-2085-3. Retrieved 30 June 2025.